Dicot Pharma is a Uppsala-based pharmaceutical company developing LIB-01, a next-generation treatment for erectile dysfunction and premature ejaculation. The company is currently advancing LIB-01 through Phase 2 clinical development, with studies to date showing improved erectile function, a sustained effect and a favourable safety profile.
Elin Trampe
CEO
Cecilia Driving
CFO
thematic
Consumer
thematic
Energy & Resources